Much of the effort in pay-for-performance programs seems cryptic to radiologists and doctors in general. For now that’s because it is not impacting our bottom line very much. That said, if you can get ahead of the curve now, you'll make things easier later when they mean more to you financially.
Much of the effort in pay for performance, CMS's new PQRI system, seems cryptic to radiologists and doctors in general. In point of fact, for now that’s because it is not impacting our bottom line very much.
That said, if you can get ahead of the curve now, you'll make things easier later when they mean more to you financially.
Designate someone in the business office to learn about pay-for-performance programs. There are many resources for this, from CMS to the ACR to the RBMA. Have this staffer find out the most up-to-date requirements and the expected payments. Then ask that an analysis be performed, specific to your practice, to show cost and benefit for implementation.
Simultaneously have the billing office educate your billing staff on these issues. They will need to audit the relevant studies for fulfillment of criteria. Keep statistics on compliance. Check with your coding software; most can provide you with statistics about how many studies of each type actually qualify. This will give you some sense of how you are doing.
The missing link is in knowing exactly how your physicians are doing in fulfilling all requirements. Auditing a sampling of your studies and providing the data to the physicians is helpful. A few extra steps can help with compliance:
• Educate the staff on what the standards are. Create a handout that lists the standards and then post them in the reading areas on large laminated placards. Review them at regular meeting with the radiologists.
• Explain why you want or need to follow the standards. Use hard numbers to show the value. Putting dollar Information is often a powerful tool to encourage compliance.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.